Bei Akademie registrieren
Argenx, NL0010832176

argenx stock faces two November investor checkpoints

Published on 11/05/2026 at 17:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
argenx stock has two scheduled management appearances in Boston and London this month. Webcasts and replays will give investors access to both discussions.

Upcoming investor conference appearances

  • argenx management is scheduled for a Guggenheim healthcare conference fireside chat in Boston.
  • A second fireside chat is planned for the Jefferies London Global Healthcare Conference.
  • Live presentations and replays will be available through the company investor website.
Argenx, NL0010832176, Illustration mit AI erstellt.
Argenx, NL0010832176, Illustration mit AI erstellt.

On November 3, argenx announced two scheduled management appearances at healthcare investor conferences in November. The company will meet investors first in Boston and then in London, with webcasts planned for both events, according to Fidelity.

What investors should watch

The first appearance is a fireside chat at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on Tuesday, November 10, at 2:00 p.m. Eastern Time. A second fireside chat is scheduled for the Jefferies London Global Healthcare Conference on Tuesday, November 17, at 8:30 a.m. Greenwich Mean Time.

The company said live webcasts will be available through its investor website. Replays are expected to remain accessible for approximately 30 days after each presentation, giving shareholders two scheduled opportunities to hear management discuss the immunology business and development portfolio.

What has changed since our last report

argenx stock traded at 817.60 euros on Lang & Schwarz at 17:00 CET on Thursday, November 5, 2026. That compares with 804.50 euros at 10:42 CET on Wednesday, November 4, in the previous report, an increase of 1.63 percent between the two quoted times. This comparison is separate from a daily exchange-session performance measure.

Investors can follow the real-time quote of argenx stock. The scheduled conference appearances are the next company communication points; the announcement itself set dates and webcast access rather than new financial guidance or clinical results.

European healthcare investors can follow the broader regional backdrop through current AEX market reports.

More company developments are available in more news and analyses on argenx stock.

argenx SE

  • Company: argenx SE
  • ISIN: NL0010832176
  • Ticker: ARGX
  • Quote: 817.60 euros on Lang & Schwarz at 17:00 CET on November 5, 2026
  • Previous report quote: 804.50 euros at 10:42 CET on November 4, 2026
Disclaimer...
en | NL0010832176 | ARGENX | boerse | 70465135 |